TY  - GEN
AU  - Coghlan,John Gerry
AU  - Galiè,Nazzareno
AU  - Barberà,Joan Albert
AU  - Frost,Adaani E
AU  - Ghofrani,Hossein-Ardeschir
AU  - Hoeper,Marius M
AU  - Kuwana,Masataka
AU  - McLaughlin,Vallerie V
AU  - Peacock,Andrew J
AU  - Simonneau,Gérald
AU  - Vachiéry,Jean-Luc
AU  - Blair,Christiana
AU  - Gillies,Hunter
AU  - Miller,Karen L
AU  - Harris,Julia H N
AU  - Langley,Jonathan
AU  - Rubin,Lewis J
TI  - Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
SN  - 1468-2060
PY  - 2017///0821
KW  - Adult
KW  - Aged
KW  - Antihypertensive Agents
KW  - therapeutic use
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Edema
KW  - chemically induced
KW  - Female
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - drug therapy
KW  - Lupus Erythematosus, Systemic
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Mixed Connective Tissue Disease
KW  - Phenylpropionates
KW  - Phosphodiesterase 5 Inhibitors
KW  - Pyridazines
KW  - Scleroderma, Systemic
KW  - Tadalafil
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1136/annrheumdis-2016-210236
ER  -